January 13, 2020

FDA releases revised draft guidance on compounding animal drugs

The U.S. Food & Drug Administration is requesting public comment on new draft Guidance for Industry (GFI) 256, “Compounding Animal Drugs from Bulk Drug Substances.” FDA said the new draft guidance, if finalized, would advise veterinarians on circumstances under which FDA does not intend to take action for certain violations of the Federal Food, Drug & Cosmetic Act (FD&C Act) when pharmacists and veterinarians compound or oversee the compounding of animal drugs from bulk drug substances.  Read more

Leave a Reply